• A man and a woman frolic around a DNA molecule

    "Cracking the Code: The Dawn of Nucleic Acid Medicines" will discuss the development of nucleic acid medicines — both the recent clinical successes, and current and upcoming challenges. By bringing together academics in basic and translational research and their peers in thriving biotechnology companies and promising start-ups, the conference aims to foster dialog and to spearhead collaborations.

  • Artistic rendering of a system for protein structure prediction.

    We are seeking a highly motivated Associate or Senior Editor to join the Nature Biotechnology team as our News Features Editor. Your mission will be to build upon the success of the journal’s front-half section, commissioning, editing and developing content that analyzes and provides our readers with updates on the most timely and significant problems in biotechnology and bioengineering.

Nature Biotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Nature Careers